These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32500462)

  • 1. Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis.
    Le Moli R; Russo M; Malandrino P; Vella V; Belfiore A; Frasca F
    Hormones (Athens); 2021 Mar; 20(1):161-165. PubMed ID: 32500462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine-Lenhart syndrome in a young girl.
    Şen Y; Cimbek EA; Yuca SA; Gedik GK; Sarı O
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):189-91. PubMed ID: 24057592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome.
    Nishikawa M; Yoshimura M; Yoshikawa N; Toyoda N; Yonemoto T; Ogawa Y; Mori S; Tabata S; Tokoro T; Sakaguchi N; Inada M
    Endocr J; 1997 Aug; 44(4):571-4. PubMed ID: 9447292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves' orbitopathy: a case series.
    Roos JCP; Moran C; Chatterjee VK; Jones J; Coles A; Murthy R
    Eye (Lond); 2019 Feb; 33(2):223-229. PubMed ID: 30498266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marine-Lenhart syndrome with papillary thyroid carcinoma.
    Atmaca H; Çolak R; Yazici ZA; Kefeli M; Tosun FC
    J Res Med Sci; 2015 Apr; 20(4):412-5. PubMed ID: 26110000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An uncommon case of Marine-Lenhart syndrome.
    Giuffrida G; Giovinazzo S; Certo R; Vicchio TM; Baldari S; Campennì A; Ruggeri RM
    Arq Bras Endocrinol Metabol; 2014 Jun; 58(4):398-401. PubMed ID: 24936736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.
    Muller I; Maioli S; Armenti M; Porcaro L; Currò N; Iofrida E; Pignataro L; Manso J; Mian C; Geginat J; Salvi M
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38471303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis.
    Duarte DB; Silva AMD; Freitas C; Cardoso H
    Endocr Regul; 2021 Sep; 55(3):169-173. PubMed ID: 34523298
    [No Abstract]   [Full Text] [Related]  

  • 9. Graves' disease after treatment with alemtuzumab for multiple sclerosis.
    Tsourdi E; Gruber M; Rauner M; Blankenburg J; Ziemssen T; Hofbauer LC
    Hormones (Athens); 2015; 14(1):148-53. PubMed ID: 25402383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of a solitary toxic thyroid nodule following Graves' disease.
    Ikekubo K; Hino M; Ito H; Otani M; Shimozato S; Nasu K; Habuchi Y; Yamaguchi H; Saiki Y; Ishihara T
    Clin Nucl Med; 1988 Oct; 13(10):748-50. PubMed ID: 2846224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis.
    Scappaticcio L; Castellana M; Virili C; Bellastella G; Centanni M; Cannavò S; Campennì A; Ruggeri RM; Giovanella L; Trimboli P
    J Endocrinol Invest; 2020 Feb; 43(2):219-229. PubMed ID: 31452116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
    Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves' disease with an autonomously functioning thyroid nodule: case report.
    Jabrocka-Hybel A; Gołkowski F; Bałdys-Waligórska A; Sokołowski G; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2009; 119(7-8):505-8. PubMed ID: 19776692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of Graves' disease associated with an autonomously functioning thyroid nodule (AFTN) (Marine-Lenhalt syndrome) which spontaneously became a cold nodule.
    Konno N; Hirokawa J; Abe S
    Endocrinol Jpn; 1988 Oct; 35(5):753-8. PubMed ID: 3220052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis.
    Rodríguez de Vera Gómez P; Méndez Muros M; Torres Cuadro A; Toyos Sáenz de Miera FJ; López Ruiz R; Guerrero Vázquez R; García González JJ; Garrido Hermosilla AM; Martín Hernández T
    J Neurol; 2024 Jan; 271(1):486-496. PubMed ID: 37773417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid progression of Graves' ophthalmopathy despite the administration of thiamazole.
    Katsuyama T; Takeda M; Otsuka F; Toma K; Inagaki K; Sada KE; Mimura Y; Ogura T; Makino H
    Intern Med; 2013; 52(20):2317-20. PubMed ID: 24126392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.